We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
Cap. Flow
-$3.6B
Cap. Flow %
-4.89%
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$38.7M
2
IFF icon
International Flavors & Fragrances
IFF
+$27.4M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$14.7M
4
COP icon
ConocoPhillips
COP
+$14.5M
5
RPRX icon
Royalty Pharma
RPRX
+$9.46M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$269M
2
MSFT icon
Microsoft
MSFT
+$172M
3
AMZN icon
Amazon
AMZN
+$114M
4
DIS icon
Walt Disney
DIS
+$62.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Financials 14.26%
3 Healthcare 12.86%
4 Consumer Discretionary 12.27%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSKE
2551
DELISTED
Daseke, Inc. Common Stock
DSKE
$439K ﹤0.01%
51,689
-2,200
-4% -$13.5K
RLGT icon
2552
Radiant Logistics
RLGT
$395M
$438K ﹤0.01%
62,982
-2,000
-3% -$13.2K
IDYA icon
2553
IDEAYA Biosciences
IDYA
$3.56B
$437K ﹤0.01%
18,608
+1,089
+6% +$21K
MCBC
2554
DELISTED
Macatawa Bank Corp
MCBC
$437K ﹤0.01%
43,889
-1,700
-4% -$15.6K
STXB
2555
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$436K ﹤0.01%
19,559
-900
-4% -$18.3K
CRNX icon
2556
Crinetics Pharmaceuticals
CRNX
$8.92B
$434K ﹤0.01%
28,397
-2,370
-8% -$36.7K
NGNE icon
2557
Neurogene
NGNE
$712M
$433K ﹤0.01%
1,760
-114
-6% -$29.1K
NAGE
2558
Niagen Bioscience
NAGE
$247M
$432K ﹤0.01%
46,296
-1,260
-3% -$9.99K
AKTS
2559
DELISTED
Akoustis Technologies Inc
AKTS
$430K ﹤0.01%
32,224
-1,160
-3% -$16.8K
HRTG icon
2560
Heritage Insurance Holdings
HRTG
$991M
$429K ﹤0.01%
38,735
-2,101
-5% -$21.9K
PHAT icon
2561
Phathom Pharmaceuticals
PHAT
$692M
$428K ﹤0.01%
11,390
-810
-7% -$33.9K
TXMD icon
2562
TherapeuticsMD
TXMD
$24M
$428K ﹤0.01%
6,392
+510
+9% +$39.9K
BCEL
2563
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$428K ﹤0.01%
27,935
-1,415
-5% -$23K
USX
2564
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$427K ﹤0.01%
36,363
-460
-1% -$4.23K
ATNX
2565
DELISTED
Athenex, Inc. Common Stock
ATNX
$426K ﹤0.01%
4,956
-10
-0.2% -$1.92K
ARD
2566
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$426K ﹤0.01%
16,782
-468
-3% -$10.1K
MAXN
2567
DELISTED
Maxeon Solar Technologies
MAXN
$422K ﹤0.01%
134
-5
-4% -$19K
FSBW icon
2568
FS Bancorp
FSBW
$320M
$421K ﹤0.01%
12,544
+240
+2% +$7.43K
PRLD icon
2569
Prelude Therapeutics
PRLD
$390M
$419K ﹤0.01%
9,661
+115
+1% +$7.63K
CVLG icon
2570
Covenant Logistics
CVLG
$872M
$418K ﹤0.01%
40,586
-1,200
-3% -$10.7K
NVEC icon
2571
NVE Corp
NVEC
$609M
$418K ﹤0.01%
5,959
-13,655
-70% -$926K
PCSB
2572
DELISTED
PCSB Financial Corporation
PCSB
$416K ﹤0.01%
25,053
-1,495
-6% -$24.5K
VOR icon
2573
Vor Biopharma
VOR
$1.28B
$414K ﹤0.01%
+480
New +$406K
EVC icon
2574
Entravision Communication
EVC
$1.1B
$413K ﹤0.01%
102,195
-4,370
-4% -$15.1K
SSTI icon
2575
SoundThinking
SSTI
$103M
$411K ﹤0.01%
11,732
+2,620
+29% +$114K
101 102
103
104 105

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.

  • RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
  • RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
  • RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
  • RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
  • RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
  • RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.